PRO32 Extended Half-Life (EHL) Recombinant Factor VIII (RFVIII) for the Treatment of Hemophilia a in Italy: Cost of Treatment Comparison

Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1017
https://www.valueinhealthjournal.com/article/S1098-3015(21)01234-1/fulltext
Title : PRO32 Extended Half-Life (EHL) Recombinant Factor VIII (RFVIII) for the Treatment of Hemophilia a in Italy: Cost of Treatment Comparison
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01234-1&doi=10.1016/j.jval.2021.04.1017
First page :
Section Title :
Open access? : No
Section Order : 10515
Categories :
Tags :
Regions :
ViH Article Tags :